Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Jordan

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Oncology|March 21, 2015
Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic MeningitisFranziska Jahn, Karin Jordan, Timo Behlendorf, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomitingChristina H Ruhlmann, Franziska Jahn, Karin Jordan, et al.
Journal of Geriatric Oncology|November 28, 2017
Erratum to "Trans sectoral care of geriatric cancer patients based on comprehensive geriatric assessment and patient-reported quality of life - Results of a multicenter study to develop and pilot test a patient-centered interdisciplinary care concept for geriatric oncology patients (PIVOG)" [J Geriatr Oncol 8 (2017) 262-270]Heike Schmidt, Stephanie Boese, Katharina Lampe, et al.
Drug Design, Development and Therapy|September 19, 2017
Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populationsBernardo Leon Rapoport, Matti Aapro, Martin R Chasen, et al.
Journal of Geriatric Oncology|May 24, 2017
Trans sectoral care of geriatric cancer patients based on comprehensive geriatric assessment and patient-reported quality of life - Results of a multicenter study to develop and pilot test a patient-centered interdisciplinary care concept for geriatric oncology patients (PIVOG)Heike Schmidt, Stephanie Boese, Katharina Lampe, et al.
The Cochrane Database of Systematic Reviews|November 16, 2021
Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysisVanessa Piechotta, Anne Adams, Madhuri Haque, et al.
Cancer Medicine|April 11, 2019
Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studiesLee Schwartzberg, Meinolf Karthaus, Giorgia Rossi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 26, 2010
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the artSteven M Grunberg, David Warr, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2023
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agentsFlorian Scotté, Lee Schwartzberg, Hirotoshi Iihara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Oncology|March 21, 2015
Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic MeningitisFranziska Jahn, Karin Jordan, Timo Behlendorf, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomitingChristina H Ruhlmann, Franziska Jahn, Karin Jordan, et al.
Journal of Geriatric Oncology|November 28, 2017
Erratum to "Trans sectoral care of geriatric cancer patients based on comprehensive geriatric assessment and patient-reported quality of life - Results of a multicenter study to develop and pilot test a patient-centered interdisciplinary care concept for geriatric oncology patients (PIVOG)" [J Geriatr Oncol 8 (2017) 262-270]Heike Schmidt, Stephanie Boese, Katharina Lampe, et al.
Drug Design, Development and Therapy|September 19, 2017
Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populationsBernardo Leon Rapoport, Matti Aapro, Martin R Chasen, et al.
Journal of Geriatric Oncology|May 24, 2017
Trans sectoral care of geriatric cancer patients based on comprehensive geriatric assessment and patient-reported quality of life - Results of a multicenter study to develop and pilot test a patient-centered interdisciplinary care concept for geriatric oncology patients (PIVOG)Heike Schmidt, Stephanie Boese, Katharina Lampe, et al.
The Cochrane Database of Systematic Reviews|November 16, 2021
Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysisVanessa Piechotta, Anne Adams, Madhuri Haque, et al.
Cancer Medicine|April 11, 2019
Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studiesLee Schwartzberg, Meinolf Karthaus, Giorgia Rossi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 26, 2010
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the artSteven M Grunberg, David Warr, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2023
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agentsFlorian Scotté, Lee Schwartzberg, Hirotoshi Iihara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Pageof 11